Our Products
We offer the best product range of Jemperli Dostarlimab 500 Mg Injection, 10 Ml Vial/ Box and Jemperli Dostarlimab 500 Mg Injection, 10 Ml Vial Per Box.
Jemperli (dostarlimab-gxly) is approved by the U.S. Food and Drug Administration (FDA) to treat mismatch repair deficient (dMMR) advanced-stage breast cancer that has grown during or after treatment if no other treatment options are available.
Additional Information:
Payment Terms : L/C, D/A, D/P, T/T, Western Union,
Packaging Details : Box
Delivery Time : 3 - 4 days
Jemperli (dostarlimab-gxly) is approved by the U.S. Food and Drug Administration (FDA) to treat mismatch repair deficient (dMMR) advanced-stage breast cancer that has grown during or after treatment if no other treatment options are available.
Additional Information:
Payment Terms : L/C, D/A, D/P, T/T, Western Union,
Packaging Details : Box
Delivery Time : 2 - 3 days